XML 39 R28.htm IDEA: XBRL DOCUMENT v3.8.0.1
Stock-Based Compensation (Tables)
9 Months Ended
Jan. 28, 2018
Summary of Assumptions Used to Determine Fair Value of Performance Based Restricted Stock Units

The following table provides assumptions used to determine the fair market value of the market-based total shareholder return component using the Monte Carlo simulation model on the date of grant:

 

Closing price of our common stock

     $32.50  

Expected volatility of our common stock

     31.0

Expected volatility of peer companies

     16.5

Risk-free interest rate

     1.56

Dividend yield

     1.66

Correlation coefficient of peer companies

     0.46  
Summary of Vested Performance Based Restricted Stock Units

The following table summarizes information related to our performance based restricted stock units that vested during the nine month periods ending January 28, 2018 and January 29, 2017:

 

            (3)         
     Common Stock      Weighted Average      Price  

Fiscal Year

   Shares Vested      Fair Value      Per Share  

Fiscal 2018 (1)

     102,845      $ 1,820      $ 17.70  (4) 

Fiscal 2018 (2)

     16,000      $ 520      $ 32.50  (5) 

Fiscal 2017 (1)

     37,192      $ 637      $ 17.12  (4) 

Fiscal 2017 (2)

     12,000      $ 345      $ 28.77  (5) 

 

(1) NEOs and key employees.
(2) Non-employee
(3) Dollar amounts are in thousands.
(4) Price per share represents closing price of our common stock on the date of grant.
(5) The respective grant vested during the first quarter of fiscal 2018 or 2017, respectively. Accordingly, the price per share represents the closing price of our common stock on the date the award vested.
NEOs and Key Employees [Member]  
Summary of Grants of Performance Based Restricted Stock Units

The following table summarizes information related to our grants of performance based restricted stock units associated with NEOs and key employees that are currently unvested:

 

     (3)               
     Restricted Stock      Price Per     Vesting  

Date of Grant

   Units Awarded      Share     Period  

July 13, 2017 (1)

     78,195      $ 31.85  (4)      3 years  

July 13, 2017 (2)

     44,000      $ 32.50  (5)      3 years  

July 14, 2016 (1) (2)

     107,880      $ 28.00  (5)      3 years  

July 15, 2015 (1) (2)

     107,554      $ 32.23  (5)      3 years  

 

(1) Performance-based restricted stock units awarded to NEOs.
(2) Performance-based restricted stock units awarded to key employees.
(3) Amounts represent the maximum number of common stock shares that could be earned if certain performance targets are met as defined in the related restricted stock unit agreements.
(4) Price per share represents the fair market value per share ($0.98 per $1 or a reduction of $0.65 to the closing price of the our common stock) determined using the Monte Carlo simulation model for the market-based total shareholder return component and the closing price of our common stock ($32.50) for the performance-based components of the performance-based restricted stock units granted to our NEOs on July 13, 2017.
(5) Price per share represents the closing price of our common stock on the date of grant.
Non-employee [Member]  
Summary of Grants of Performance Based Restricted Stock Units

The following table summarizes information related to our grants of performance-based restricted stock units associated with a non-employee that are currently unvested:

 

     (1)               
     Restricted Stock      Price Per     Vesting  

Date of Grant

   Units Awarded      Share     Period  

July 13, 2017

     10,200      $ 31.35  (2)      3 years  

July 14, 2016

     11,549      $ 31.35  (2)      3 years  

July 15, 2015

     10,364      $ 31.35  (2)      3 years  

 

(1) Amounts represent the maximum number of common stock shares that could be earned if certain performance targets are met as defined in the related restricted stock unit agreements.
(2) The respective grant was unvested at the end of our reporting period. Accordingly, the price per share represents the closing price of our common stock on January 28, 2018, the end of our reporting period.